AMYT Amryt Pharma plc ADRs

We are a global, commercial-stage biopharmaceutical company dedicated to commercializing and developing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:AMYT.

$7.31  +0.12 (1.67%)
As of 10/05/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  United Kingdom
Country of incorporation:  
IPO date:  07/08/2020
Outstanding shares:  63,962,949
Average volume:  36,064
Market cap:   $441,983,978
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -28.96
PB ratio:   1.35
PS ratio:   1.90
Return on equity:   -4.66%
Net income %:   -6.91%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy